Predictions:
- Futures are up for the most part Futures as of 10pm central time
- Looks as if we will have an up day tomorrow at the start who knows it may shoot down from that point, Hang Seng up
- Vertex Pharma (VRTX, 33.95close, 38.31ah's) advanced in night trade on the back of positive viral response data in a hepatitis C virus study. VRTX vaulted north from 34.01 to a high of 39 early in night trade. It backed down to still plus-side levels between 37.75 and 38.40 through the rest of the session. A pre-bell open Wednesday may have potential surrounding 38. There was some steady sell pressure that hit VRTX between the high of 39 and 38, levels shorts may want to eye if this top again has trouble holding support early tomorrow. On the long side, early buyers may want to watch the 37.50 to 38 area at the start Wednesday, levels that may have legs to catch some morning interest and perhaps see some revisits to the high 37s or above 38.
- Price: 38.13, Change: +4.18, Percent Change: +12.3
- GTx, Inc. (GTXI:$3.02,00$-0.23,00-7.08%) tumbled lower in after-hours trade after reporting prostate cancer trial results that were not statistically significant.
GTXI cratered to an early after-hours low of 1.72 before popping back to about 2.24. It dropped to lower levels between 2.00 and 1.76 through the first-half of night play. Buyers grew more confident in the issue into the mid-session, goosing it to still downside levels between 2.08 and 1.85. It steadied between 2.03 and 1.90 into the second-half. A pre-bell open Wednesday may have potential near 2.10 to 1.90. With buyers active off the low of 1.72 up to 1.90 tonight, more risk tolerant longs may want to watch this area as a potential floor support that could see bumps back up near 2.00 or above. More aggressive longs may want to sit closer to the 2.00 to 1.90 area in anticipation of this level catching some early day interest and possibly firming deeper into low-2s. - Price: 1.96, Change: -1.06, Percent Change: -35.
- NZ: +6.4%; beats Q1 estimates.
- TIVO (TIVO:$9.15,00$0.10,001.10%) : -1.8%; Q1 loss widens but beats Street view by a penny.
- GTXI: -35%; says prostate cancer trial results not statistically significant.
- VRTX: +11.9%; reports positive viral response in Hep C study.
- Dycom Industries, Inc. (DY:$8.50,00$0.07,000.83%) announced today its results for the third quarter ended April 24, 2010.
- IXYS Corp (IXYS:$8.47,00$0.00,000.00%) swung to a fourth-quarter profit, beating market estimates, as bookings rose and the chipmaker forecast first-quarter revenue well above Wall Street expectations, sending its shares up 12 percent after the bell.
- GT Solar International, Inc. (SOLR:$5.27,00$-0.32,00-5.72%) reported consolidated unaudited earnings results for the fourth quarter and full year ended April 3, 2010. For the quarter, revenue was $194,676,000 against $138,544,000 a year ago. Income from operations was $55,330,000 against $21,245,000 a year ago. Income before income taxes was $54,410,000 against $19,890,000 a year ago. Net income was $33,271,000 or $0.23 per basic and diluted share against $11,759,000 or $0.08 per basic and diluted share a year ago.
- For the full year, revenue was $544,245,000 against $541,027,000 a year ago. Income from operations was $143,962,000 against $143,544,000 a year ago. Income before income taxes was $139,874,000 against $142,180,000 a year ago. Net income was $87,256,000 or $0.60 per diluted share against $87,968,000 or $0.61 per diluted share a year ago.
- The company revised earnings guidance for the full year of fiscal 2011, For the year revenue and EPS guidance to the upper end of its previous range with revenue of $550 million to $600 million and fully diluted earnings per share of $0.55 to $0
- Ener1, Inc. (HEV:$2.90,00$-0.10,00-3.33%) : The most recent annual report, and if applicable, quarterly report, is available at no fee. This one has moved a few days after earnings.
- Neurocrine Biosciences (NBIX:$3.40,00$0.67,0024.54%) shares rallied almost 30% to $3.49.
Late Monday, Neurocrine reported positive Phase II data from a clinical trial for its drug candidate elagolix in the treatment of endometriosis, an often painful gynecological condition. - Motorola Inc. (MOT:$6.75,00$0.02,000.30%) is exploring potential locations, including San Diego, for the headquarters of its mobile phone and cable set-top-box business, which is slated to be split from the rest of the company next year.
- Watch List :
- C - 3.89
- F - 11.15
- UCO -8.56
- Netezza (NZ:$13.16,00$-0.06,00-0.45%) shares are consistently being matched at 14 through the after-hours. Buy liquidity has been strong at this level.
- Kearny Financial Corp. (KRNY:$9.35,00$0.01,000.11%) ("Kearny"), the holding company for Kearny Federal Savings Bank, and Central Jersey Bancorp (CJBK:$3.08,00$-0.173,0-5.32%) ("Central Jersey"), the holding company for Central Jersey Bank, N. A., jointly announced the execution of a definitive merger agreement which provides for the acquisition of Central Jersey by Kearny in an all cash transaction valued at $7.50 per share and an aggregate deal value of approximately $72.3 million. The definitive merger agreement is subject to approval by Central Jersey's shareholders and applicable banking regulatory authorities. It is anticipated that the merger will close in the fourth calendar quarter of 2010. Kearny's management projects that the transaction will be $0.05 per share accretive to annual GAAP earnings per share in the first full year of combined operations. The dilution to tangible book value per share at close is projected to be approximately 8%
- Hanmi Financial: Woori To Buy Hanmi Stock At $1.20 Per Share >HAFC.
- Fidelity National Information Services (FIS:$26.56,00$0.44,001.68%) said its board approved a plan for the payment processing company to borrow more and use the funds to buy back as much as $2.5 billion of its shares.
- Up to $28 ah's.
- American Eagle Outfitters (AEO:$15.38,00$0.15,000.98%) is forecast to report first-quarter earnings of 17 cents a share, according to a consensus survey by Thomson Reuters.
- Jamba Inc. (JMBA:$2.67,00$-0.08,00-2.91%) is projected to have earnings of 13 cents a share, according to analysts polled by FactSet Research.
- Jo-Ann Stores (JAS:$42.88,00$0.26,000.61%) is expected to post first-quarter earnings of 44 cents a share, according to Thomson Reuters.
- NetApp (NTAP:$33.09,00$0.69,002.13%) is forecast to report fourth-quarter earnings of 44 cents a share, according to Thomson Reuters.
- TiVo Inc. (TIVO:$9.15,00$0.10,001.10%) said Tuesday its first-quarter net loss widened to $14.2 million, or 13 cents a share, from the year-ago period as revenue declined and the company's subscriber-acquisition costs increased. A year ago, the company lost $3.9 million, or 4 cents a share. Analysts were expecting a loss of 16 cents a share on service/technology revenue of $42.8 million, according to consensus forecasts from Thomson Reuters.
- JS Acquisition, which was formed by Emmis (EMMS:$2.14,00$-0.02,00-0.93%) Chairman and Chief Executive Jeffrey H. Smulyan, will make a tender offer for Emmis's (EMMS:$2.14,00$-0.02,00-0.93%) common stock at $2.40 in cash and an offer to exchange senior subordinated notes for Emmis's (EMMS:$2.14,00$-0.02,00-0.93%) preferred stock. The deal also includes amendments to preferred stock and a back-end merger that will cash out any common stock that isn't tendered at $2.40.
TIVO, -1.6%
GTXI, -35%
VRTX, +12.3%
POZN, +3.7%
ATAC, +0.01%
NZ, +6.4%
LEN, -0.5%
UPSIDE MOVERS:
VRTX: 33.69 to 39
POZN: 7.51 to 7.9
ATAC: 17.39 to 18.10
NZ: 13.06 to 14.04
DOWNSIDE MOVERS:
TIVO: 9.49 to 8.88
GTXI: 3.27 to 1.72
LEN: 17.30 to 16.78
- Japanese steel producer JFE Holdings Inc. is set to go on an emerging-markets acquisition binge, funded by a 700 billion yen ($7.74 billion) war chest, according to a report Wednesday. The push will involve taking stakes in businesses that supply local markets, with JFE already in talks to take a roughly 10% interest in Indian peer and joint-venture partner JSW Steel Ltd. , the Nikkei business daily reported, citing unidentified sources. JFE also plans to raise its crude steel capacity in Japan to 33 million tons a year by fiscal 2011, marking a 10% increase from fiscal 2007.
- EDC Emerging Markets Bull Fund you can benefit in a similar way by playing this fund.
